AKT1 and acute myeloid leukemia: Bertacchini et al. 85 demonstrated that pharmacological inhibitors of PI3K (LY294002) and AKT (AKTi 1/2) induced apoptosis but could not abrogate the phosphorylation of AKT at serine 473 and threonine 308 in a group of primary AML samples.